GlassScriptPhysician profile
Steven J Nisco
NPI 1093713943
$9,359.73
in general payments reported to CMS, 2019-2025
14 companies · $4,789 in 2025
The $4,789 reported for 2025 was more than what 82% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,055 · 2020: $499 · 2021: $275 · 2022: $219 · 2023: $140 · 2024: $383 · 2025: $4,789.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,500 · Travel and Lodging: $1,705 · Food and Beverage: $1,108.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,500.00 |
| Travel and Lodging | $1,704.75 |
| Food and Beverage | $1,107.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,038.45 | 2019-2025 | |
| Edwards Lifesciences Corporation | $1,074.56 | 2019-2025 | Edwards Intuity Elite Valve System, Inspiris Resilia Aortic Valve |
| Medtronic Vascular, INC. | $333.40 | 2019-2020 | |
| Baxter Healthcare | $219.88 | 2019-2021 | |
| W. L. Gore & Associates, INC. | $144.61 | 2020-2025 | Gore Tag Thoracic Branch Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Tag Thoracic Endoprosthesis |
| Astrazeneca Pharmaceuticals LP | $125.00 | 2019 | |
| Amgen INC. | $98.95 | 2024 | Evenity |
| Atricure, INC. | $92.92 | 2023-2024 | |
| Abbott Laboratories | $61.35 | 2022 | |
| Olympus America INC. | $55.64 | 2020-2021 | |
| Clearflow INC. | $43.18 | 2020 | |
| Abiomed | $32.54 | 2024 | Impella |
| Zimmer Biomet Holdings, INC. | $27.40 | 2023 | Sternalock Blu System |
| Davol INC. | $11.85 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Nisco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.